{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:15:45Z","timestamp":1759616145272,"version":"3.37.3"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015756","name":"Janssen-Cilag","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"crossref"}]},{"name":"\u00c5hl\u00e9n Stiftelsen"},{"DOI":"10.13039\/501100005967","name":"Linnaeus University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005967","id-type":"DOI","asserted-by":"publisher"}]},{"name":"California Northstate University College of Medicine"},{"DOI":"10.13039\/501100004434","name":"University of Florence","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbr.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T16:15:24Z","timestamp":1499098524000},"page":"129-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat"],"prefix":"10.1016","volume":"333","author":[{"given":"Marie-Louise G.","family":"Wadenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Novella","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo R.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2017.07.001_bib0005","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1176\/ajp.2007.164.7.992","article-title":"Cognition, drug treatment and functional outcome in schizophrenia: a tale of two transitions","volume":"164","author":"Green","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"The effects of clozapine risperidone, and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbr.2017.07.001_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/NDT.S120843","article-title":"Risperidone improves interpersonal perception and executive function in patients with schizophrenia","volume":"13","author":"Zhou","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbr.2017.07.001_bib0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2008.12.017","article-title":"Association of the 5\u2019-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia","volume":"109","author":"Stephens","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbr.2017.07.001_bib0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0074-7742(06)78008-4","article-title":"Schizophrenia and the alpha7 nicotinic acetylcholine receptor","volume":"78","author":"Martin","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.bbr.2017.07.001_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainresbull.2012.11.003","article-title":"\u03b17 nicotinic acetylcholine receptors and their role in cognition","volume":"93","author":"Lendvai","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbr.2017.07.001_bib0035","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/jpet.102.045773","article-title":"Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors","volume":"305","author":"Samochocki","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2017.07.001_bib0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.npp.1301087","article-title":"Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentation of nicotinic acetylcholine receptors","volume":"32","author":"Schilstr\u00f6m","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2017.07.001_bib0045","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1176\/appi.ajp.159.7.1244","article-title":"Galantamine for treatmentresistant schizophrenia","volume":"159","author":"Allen","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopsych.2006.04.006","article-title":"Galantamine improves cognition in schizophrenic patients stabilized on risperidone","volume":"60","author":"Schubert","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0055","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0006-3223(93)90009-3","article-title":"Physostigmine ameliorates the delusions of Alzheimer\u2019s disease","volume":"33","author":"Cummings","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0060","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2174\/138161210790170085","article-title":"Conditioned avoidance response in the development of new antipsychotics","volume":"16","author":"Wadenberg","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbr.2017.07.001_bib0065","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1017\/S1461145710000921","article-title":"Effects of adjunct galantamine to risperidone or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor","volume":"14","author":"Wadenberg","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2017.07.001_bib0070","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.neuropharm.2006.12.007","article-title":"Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model","volume":"52","author":"Wang","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2017.07.001_bib0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00001756-199504190-00011","article-title":"Ketamine activates psychosis and alters limbic blood flow in schizophrenia","volume":"6","author":"Lahti","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2017.07.001_bib0080","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/ajp.154.6.805","article-title":"Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers","volume":"154","author":"Breier","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.biopsycho.2006.01.005","article-title":"Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats monkeys and humans","volume":"73","author":"Chudasama","year":"2006","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.bbr.2017.07.001_bib0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(98)00156-X","article-title":"Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage","volume":"37","author":"Pantelis","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbr.2017.07.001_bib0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/B978-0-12-381264-3.00005-9","article-title":"Positive and negative modulation of nicotinic receptors","volume":"80","author":"Arias","year":"2010","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.bbr.2017.07.001_bib0100","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1021\/bi102001m","article-title":"Novel positive allosteric modulators of the human \u03b17 nicotinic acetylcholine receptor","volume":"50","author":"Arias","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.biocel.2016.04.015","article-title":"Positive allosteric modulators of \u03b17 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor \u03b2-amyloid content","volume":"76","author":"Arias","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbr.2017.07.001_bib0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuropharm.2016.02.032","article-title":"Exploring the positive allosteric modulation of human \u03b17 nicotinic receptors from a single-channel perspective","volume":"107","author":"Andersen","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2017.07.001_bib0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbr.2016.01.002","article-title":"The positive allosteric modulator of \u03b17 nicotinic acetylcholine receptors 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1\/2 phosphorylation in mice","volume":"302","author":"Targowska-Duda","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2017.07.001_bib0120","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1111\/bph.13277","article-title":"Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the \u03b17 nicotinic acetylcholine receptor","volume":"172","author":"Potasiewicz","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"Pt A","key":"10.1016\/j.bbr.2017.07.001_bib0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neuropharm.2016.10.002","article-title":"3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the \u03b17 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats","volume":"113","author":"Potasiewicz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2017.07.001_bib0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00213-008-1132-9","article-title":"Comparison of haloperidol risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat \u2013 a back translational study","volume":"202","author":"Goetghebeur","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2017.07.001_bib0135","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/npp.2011.298","article-title":"Selective remediation of reversal learning deficits in the neurodevelopmental MAM model of schizophrenia by a novel mGlu5 positive allosteric modulator","volume":"37","author":"Gastambide","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2017.07.001_bib0140","series-title":"Introduction to Experimental Statistics","first-page":"207","author":"Li","year":"1964"},{"key":"10.1016\/j.bbr.2017.07.001_bib0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-3223(90)90657-N","article-title":"Suppression of conditioned avoidance behavior by the local application of (-)sulpiride into the ventral but not the dorsal, striatum of the rat","volume":"28","author":"Wadenberg","year":"1990","journal-title":"Biol. Psychiatry"},{"year":"1988","series-title":"Nonparametric Statistics for the Behavioral Sciences","author":"Siegel","key":"10.1016\/j.bbr.2017.07.001_bib0150"},{"key":"10.1016\/j.bbr.2017.07.001_bib0155","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","volume":"93","author":"Laruelle","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2017.07.001_bib0160","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.biopsych.2008.12.007","article-title":"Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects","volume":"65","author":"Abi-Dargham","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0165","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0006-3223(01)01252-5","article-title":"Prefrontal neurons and the genetics of schizophrenia","volume":"50","author":"Weinberger","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0170","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.pnpbp.2003.09.009","article-title":"Alpha2-adrenoceptor modulation hypothesis of antipsychotic atypicality","volume":"27","author":"Svensson","year":"2003","journal-title":"Progr. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0175","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-011-2539-2","article-title":"Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine","volume":"220","author":"Alexander","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2017.07.001_bib0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/glia.20432","article-title":"Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry","volume":"55","author":"Guidetti","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.bbr.2017.07.001_bib0185","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2017.07.001_bib0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1124\/jpet.107.123109","article-title":"Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7 nicotinic receptors","volume":"322","author":"Lopes","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2017.07.001_bib0195","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/14728222.2013.736498","article-title":"Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia","volume":"17","author":"Wallace","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbr.2017.07.001_bib0205","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.2174\/1381612819666131216121019","article-title":"Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia","volume":"20","author":"Boggs","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbr.2017.07.001_bib0210","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/appi.ajp.2007.07050724","article-title":"Galantamine for the treatment of cognitive impairments in people with schizophrenia","volume":"165","author":"Buchanan","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0215","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archpsyc.63.6.630","article-title":"Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia","volume":"63","author":"Olincy","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0220","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1176\/appi.ajp.2008.07071135","article-title":"Initial phase 2 trial of a nicotinic agonist in schizophrenia","volume":"165","author":"Freedman","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2017.07.001_bib0225","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-013-3275-6","article-title":"Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting in rats","volume":"231","author":"Jones","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2017.07.001_bib0230","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuropharm.2015.07.034","article-title":"Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats","volume":"101","author":"Nikiforuk","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817306800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817306800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T15:55:15Z","timestamp":1655394915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432817306800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":46,"alternative-id":["S0166432817306800"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2017.07.001","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}